Theralite dialysis membrane launched; could restore kidney function in cancer patients
This article was originally published in Clinica
Executive Summary
Gambro has launched Theralite, a semi-permeable membrane intended to filter harmful proteins out of cancer patients' blood. It is designed to be employed in a form of dialysis to treat the acute kidney failure often seen in patients with multiple myeloma (MM), and Gambro believes it can actually reverse the progression of kidney failure.